IN.TO - InMed Pharmaceuticals Inc.

Toronto - Toronto Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 5
38.87M
Enterprise Value 3
26.28M
Trailing P/E
N/A
Forward P/E 1
-2.18
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
2.76
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
-1.80

Trading Information

Stock Price History

Beta (3Y Monthly) 3.43
52-Week Change 3-40.74%
S&P500 52-Week Change 315.63%
52 Week High 30.8000
52 Week Low 30.2150
50-Day Moving Average 30.2591
200-Day Moving Average 30.3117

Share Statistics

Avg Vol (3 month) 3127.32k
Avg Vol (10 day) 392.54k
Shares Outstanding 5172.28M
Float 167.71M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Nov 15, 2019) 4151.61k
Short Ratio (Nov 15, 2019) 41.25
Short % of Float (Nov 15, 2019) 4N/A
Short % of Shares Outstanding (Nov 15, 2019) 40.09%
Shares Short (prior month Oct 15, 2019) 4146.97k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 215/1
Last Split Date 3Dec 31, 2009

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2019
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-42.66%
Return on Equity (ttm)-70.26%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -14.61M
Net Income Avi to Common (ttm)-14.3M
Diluted EPS (ttm)-0.0830
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.71M
Total Cash Per Share (mrq)0.09
Total Debt (mrq)503.92k
Total Debt/Equity (mrq)3.36
Current Ratio (mrq)10.30
Book Value Per Share (mrq)0.09

Cash Flow Statement

Operating Cash Flow (ttm)-10.17M
Levered Free Cash Flow (ttm)-5.12M